{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:15:51Z","timestamp":1786997751387,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.trim.2026.102379","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:49:18Z","timestamp":1773906558000},"page":"102379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preformed HNA-3a antibodies in renal transplantation: A suggested approach to risk assessment"],"prefix":"10.1016","volume":"96","author":[{"given":"Rishabh","family":"Suvarna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Daga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2026.102379_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10930-010-9268-y","article-title":"Isoforms, expression, glycosylation, and tissue distribution of CTL2\/SLC44A2","volume":"29","author":"Kommareddi","year":"2010","journal-title":"Protein J."},{"issue":"5","key":"10.1016\/j.trim.2026.102379_bb0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000491031","article-title":"Molecular genetics of the human neutrophil antigens","volume":"45","author":"Flesch","year":"2018","journal-title":"Transfus. Med. Hemother."},{"issue":"11","key":"10.1016\/j.trim.2026.102379_bb0015","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1537-2995.2012.03600.x","article-title":"Determination of neutrophil antigen HNA-3a and HNA-3b genotype frequencies in six racial groups by high-throughput 5\u2032 exonuclease assay","volume":"52","author":"Bowens","year":"2012","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.trim.2026.102379_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1399-0039.2012.01930.x","article-title":"The frequencies of human neutrophil alloantigens among the Japanese population","volume":"80","author":"Matsuhashi","year":"2012","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.trim.2026.102379_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12967-018-1447-1","article-title":"HNA-3a and HNA-3b antigens among 9 ethnic populations and the Han population in Southwest China","volume":"16","author":"Ou","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.trim.2026.102379_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101905","article-title":"Kidney transplant outcomes in patients with antibodies to human neutrophil antigen 3a","volume":"81","author":"Cannon","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.trim.2026.102379_bb0035","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1097\/01.tp.0000542873.30386.b8","article-title":"Human neutrophil antibodies are associated with severe early rejection in kidney transplant recipients","volume":"102","author":"Key","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2026.102379_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/iji.12514","article-title":"Human neutrophil antigens: nature, clinical significance and detection","volume":"48","author":"Browne","year":"2021","journal-title":"Int. J. Immunogenet."},{"issue":"2","key":"10.1016\/j.trim.2026.102379_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.177.2.557","article-title":"An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles","volume":"177","author":"Wilson","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trim.2026.102379_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703457","article-title":"Non-HLA antibodies and epitope mismatches in kidney transplant recipients with histological antibody-mediated rejection","volume":"12","author":"Crespo","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.trim.2026.102379_bb0055","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s00467-021-04969-1","article-title":"Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients","volume":"36","author":"Fichtner","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.trim.2026.102379_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.809059","article-title":"The pre-transplant non-HLA antibody burden associates with the development of histology of antibody-mediated rejection after kidney transplantation","volume":"13","author":"Senev","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.trim.2026.102379_bb0065","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1111\/ajt.15871","article-title":"Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation","volume":"20","author":"See","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.trim.2026.102379_bb0070","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ekir.2022.03.006","article-title":"Principles of virtual crossmatch testing for kidney transplantation","volume":"7","author":"Bhaskaran","year":"2022","journal-title":"Kidney Int. Rep."},{"issue":"2","key":"10.1016\/j.trim.2026.102379_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/TP.0b013e3181c926f2","article-title":"Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation","volume":"89","author":"Taylor","year":"2010","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2026.102379_bb0080","article-title":"Characterisation of the novel HLA-DQA1*01:169 allele by sequencing-based typing","volume":"105","author":"Cargou","year":"2025","journal-title":"HLA"},{"issue":"6","key":"10.1016\/j.trim.2026.102379_bb0085","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/tri.13874","article-title":"Stratifying the humoral risk of candidates to a solid organ transplantation: a proposal of the ENGAGE working group","volume":"34","author":"Bestard","year":"2021","journal-title":"Transpl. Int."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:48:44Z","timestamp":1780296524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"alternative-id":["S0966327426000377"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102379","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preformed HNA-3a antibodies in renal transplantation: A suggested approach to risk assessment","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102379"}}